June 9, 2021

FDA Approval of a New Treatment: What’s Next for the Alzheimer’s Community?

Thumbnail

FDA Approval of a New Treatment: What’s Next for the Alzheimer’s Community?

About This Episode

The Food and Drug Administration (FDA) has approved aducanumab as a new treatment for early-stage Alzheimer’s disease, and this AlzTalks explores what this means for the Alzheimer’s community.

Host Meryl Comer talked about the drug treatment with Biogen’s Samantha Budd Haeberlein, PhD, SVP, Head of Neurodegeneration Development and Karin Hellsvik, Head, External Communications and Patient Advocacy, and had a conversation about the decision with George Vradenburg, chairman and co-founder of UsAgainstAlzheimer’s; Russ Paulsen, UsA’s chief operating officer; and Jason Resendez, executive director of the UsAgainstAlzheimer’s Center for Brain Health Equity. 

Meryl Comer also spoke about this new drug with advocates Jim and Geri Taylor. Geri, who lives with Alzheimer’s disease, participated in the clinical trial for this therapy.

Press the 'Play' button under the image at left to hear a podcast of the conversation, or watch the full session HERE.

BrainStorm Feed

94

The Unexpected Journey - Emma Heming Willis on Caregiving for Bruce Willis

In this deeply moving episode of BrainStorm by UsAgainstAlzheimer’s, Emma Heming Willis shares her intimate journey as a caregiver to her husband Bruce Willis, who lives with frontotemporal dementia.
LISTEN NOW
92

Navigating Alzheimer's Care: When to Seek Help and How to Stay in Control with Dr. Carolyn Clevenger

In this episode of BrainStorm by UsAgainstAlzheimer’s Dr. Carolyn Clevenger, Founder and Director of Emory's innovative Integrated Memory Care Clinic continues to explore the complex realities of Alzheimer's caregiving with host Meryl Comer.
LISTEN NOW
91

Managing Agitation in Dementia: Expert Insights on Integrated Care and Caregiver Support with Dr. Carolyn Clevenger (part 1)

In this episode of BrainStorm by UsAgainstAlzheimer's, host Meryl Comer explores the critical issue of agitation in dementia care with Dr. Carolyn Clevenger, Founder and Director of Emory's Integrated Memory Care Clinic.
LISTEN NOW